Erythromycin C（Erythromycin impurities 13）
CAS number: 1675-02-1
Product Code: REF-E33034
Molecular formula: C36H65NO13
Molecular weight: 719.91
Purity: 98.99%
Product nature: Customized for customers
Appearance: White powder
Storage conditions:- 20℃
Chemical name: (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-(((2R,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
Erythromycin C (Erythromycin Impurity 13), Erythromycin C (Erythromycin Impurity 13) Standard, Erythromycin C (Erythromycin Impurity 13) Reference
Hot Tags:Erythromycin C（Erythromycin impurities 13）, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock。
Synthesis of Erythromycin C（Erythromycin impurities 13）
Erythromycin C（Erythromycin impurities 13） Reference Standards,
Complex Impurity Of Erythromycin C（Erythromycin impurities 13）
Chemical Standards of Erythromycin C（Erythromycin impurities 13）
Characterization Of Unknown Impurities of Erythromycin C（Erythromycin impurities 13）
Structure Profiling of Erythromycin C（Erythromycin impurities 13）
Identification of Erythromycin C（Erythromycin impurities 13）
Isolation & Purification of Impurity of Erythromycin C（Erythromycin impurities 13）
Difficult of Erythromycin C（Erythromycin impurities 13）
Instability of Erythromycin C（Erythromycin impurities 13）
Low-assay of Erythromycin C（Erythromycin impurities 13）
Complex Impurity Of Chemical Standards of Erythromycin C（Erythromycin impurities 13）
TOSUN PHARM was established in 1999. In China, it is a collection of drugs, APIs, reference listed drugs, impurities, excipients, intermediates import and export, import registration services, generic drug research and development services, innovative drugs and high-end FDF technology transfer, A group company integrating marketing, academic promotion and cooperative production. With a global procurement, R&D and marketing network, it can quickly meet the needs of product R&D, production and market sales of Chinese and global pharmaceutical companies.
China
